Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

OBJECTIVE: The present study was undertaken to evaluate the probability of achieving the Clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA) treatment targets of remission or low disease activity (LDA) with apremilast based on disease activity categories and corresponding responses in a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Care Res (Hoboken)
Main Authors: Mease, Philip J., Gladman, Dafna D., Ogdie, Alexis, Coates, Laura C., Behrens, Frank, Kavanaugh, Arthur, McInnes, Iain, Queiro, Rubén, Guerette, Benoit, Brunori, Michele, Teng, Lichen, Smolen, Josef S.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Psoriatic Arthritis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7317912/
https://ncbi.nlm.nih.gov/pubmed/31909868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.24134
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares